209 research outputs found

    Investigating magneto-chemical interactions at molecule-substrate interfaces by X-ray photo-emission electron microscopy

    Get PDF
    The magneto-chemical interaction of spin-bearing molecules with substrates is interesting from a coordination chemistry point of view and relevant for spintronics. Unprecedented insight is provided by X-ray photo-emission electron microscopy combined with X-ray magnetic circular dichroism spectroscopy. Here the coupling of a Mn-porphyrin ad-layer to the ferromagnetic Co substrate through suitably modified interfaces is analyzed with this technique

    Emergence of On-Surface Magnetochemistry

    Get PDF
    The control of exchange coupling across the molecule–substrate interface is a key feature in molecular spintronics. This Perspective reviews the emerging field of on-surface magnetochemistry, where coordination chemistry is applied to surface-supported metal porphyrins and metal phthalocyanines to control their magnetic properties. The particularities of the surface as a multiatomic ligand or “surface ligand” are introduced. The asymmetry involved in the action of a chemical ligand and a surface ligand on the same planar complexes modifies the well-established “trans effect” to the notion of the “surface-trans effect”. As ad-complexes on ferromagnetic substrates are usually exchange-coupled, the magnetochemical implications of the surface-trans effect are of particular interest. The combined action of the different ligands allows for the reproducible control of spin states in on-surface supramolecular architectures and opens up new ways toward building and operating spin systems at interfaces. Notably, spin-switching has been demonstrated to be controlled collectively via the interaction with a ligand (chemical selectivity) and individually via local addressing at the interface

    Surface operators, dual quivers and contours

    Get PDF
    We study half-BPS surface operators in four dimensional N=2 SU(N) gauge theories, and analyze their low-energy effective action on the four dimensional Coulomb branch using equivariant localization. We also study surface operators as coupled 2d/4d quiver gauge theories with an SU(N) flavour symmetry. In this description, the same surface operator can be described by different quivers that are related to each other by two dimensional Seiberg duality. We argue that these dual quivers correspond, on the localization side, to distinct integration contours that can be determined by the Fayet-Iliopoulos parameters of the two dimensional gauge nodes. We verify the proposal by mapping the solutions of the twisted chiral ring equations of the 2d/4d quivers onto individual residues of the localization integrand.Comment: 42 pages. v2: Sections 4 and 5 partially restructured in order to describe in a more compact ad unified way the association of contours to quiver

    Hypertension and Cognitive Health Among Older Adults in India

    Full text link
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/156445/2/jgs16741.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/156445/1/jgs16741_am.pd

    Magnetic exchange coupling of a synthetic Co(II)-complex to a ferromagnetic Ni substrate

    Get PDF
    On-surface assembly of a spin-bearing and non-aromatic porphyrin-related synthetic Co(II)-complex on a ferromagnetic Ni thin film substrate and subsequent magnetic exchange interaction across the interface were studied by scanning tunnelling microscopy (STM), X-ray absorption spectroscopy (XAS), X-ray magnetic circular dichroism (XMCD) and density functional theory +U (DFT + U) calculations

    Antiferromagnetic coupling of Cr-porphyrin to a bare Co substrate

    Get PDF
    We report the discovery of an antiferromagnetic coupling of the magnetic moment of chromium(II) tetraphenyl-porphyrin (CrTPP) molecules to the magnetization of the clean ferromagnetic Co(001) substrate. We assign this unusual molecule-substrate exchange coupling to the less than half-filled chromium 3d orbitals interacting with Co valence band electrons via porphyrin-ligand molecular orbitals. X-ray magnetic circular dichroism, x-ray photoelectron spectroscopy, and scanning tunneling microscopy are combined with DFT+U calculations and provide evidence for a surprising type of antiferromagnetic 90∘ indirect magnetic exchange coupling

    Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Get PDF
    Background Previous attempts to characterise the burden of chronic respiratory diseases have focused only on specific disease conditions, such as chronic obstructive pulmonary disease (COPD) or asthma. In this study, we aimed to characterise the burden of chronic respiratory diseases globally, providing a comprehensive and up-to-date analysis on geographical and time trends from 1990 to 2017. Methods Using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017, we estimated the prevalence, morbidity, and mortality attributable to chronic respiratory diseases through an analysis of deaths, disability-adjusted life-years (DALYs), and years of life lost (YLL) by GBD super-region, from 1990 to 2017, stratified by age and sex. Specific diseases analysed included asthma, COPD, interstitial lung disease and pulmonary sarcoidosis, pneumoconiosis, and other chronic respiratory diseases. We also assessed the contribution of risk factors (smoking, second-hand smoke, ambient particulate matter and ozone pollution, household air pollution from solid fuels, and occupational risks) to chronic respiratory disease-attributable DALYs. Findings In 2017, 544·9 million people (95% uncertainty interval [UI] 506·9–584·8) worldwide had a chronic respiratory disease, representing an increase of 39·8% compared with 1990. Chronic respiratory disease prevalence showed wide variability across GBD super-regions, with the highest prevalence among both males and females in high-income regions, and the lowest prevalence in sub-Saharan Africa and south Asia. The age-sex-specific prevalence of each chronic respiratory disease in 2017 was also highly variable geographically. Chronic respiratory diseases were the third leading cause of death in 2017 (7·0% [95% UI 6·8–7·2] of all deaths), behind cardiovascular diseases and neoplasms. Deaths due to chronic respiratory diseases numbered 3 914 196 (95% UI 3 790 578–4 044 819) in 2017, an increase of 18·0% since 1990, while total DALYs increased by 13·3%. However, when accounting for ageing and population growth, declines were observed in age-standardised prevalence (14·3% decrease), agestandardised death rates (42·6%), and age-standardised DALY rates (38·2%). In males and females, most chronic respiratory disease-attributable deaths and DALYs were due to COPD. In regional analyses, mortality rates from chronic respiratory diseases were greatest in south Asia and lowest in sub-Saharan Africa, also across both sexes. Notably, although absolute prevalence was lower in south Asia than in most other super-regions, YLLs due to chronic respiratory diseases across the subcontinent were the highest in the world. Death rates due to interstitial lung disease and pulmonary sarcoidosis were greater than those due to pneumoconiosis in all super-regions. Smoking was the leading risk factor for chronic respiratory disease-related disability across all regions for men. Among women, household air pollution from solid fuels was the predominant risk factor for chronic respiratory diseases in south Asia and sub-Saharan Africa, while ambient particulate matter represented the leading risk factor in southeast Asia, east Asia, and Oceania, and in the Middle East and north Africa super-region. Interpretation Our study shows that chronic respiratory diseases remain a leading cause of death and disability worldwide, with growth in absolute numbers but sharp declines in several age-standardised estimators since 1990. Premature mortality from chronic respiratory diseases seems to be highest in regions with less-resourced health systems on a per-capita basis

    Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017

    Get PDF
    Background Although the burden of influenza is often discussed in the context of historical pandemics and the threat of future pandemics, every year a substantial burden of lower respiratory tract infections (LRTIs) and other respiratory conditions (like chronic obstructive pulmonary disease) are attributable to seasonal influenza. The Global Burden of Disease Study (GBD) 2017 is a systematic scientific effort to quantify the health loss associated with a comprehensive set of diseases and disabilities. In this Article, we focus on LRTIs that can be attributed to influenza. Methods We modelled the LRTI incidence, hospitalisations, and mortality attributable to influenza for every country and selected subnational locations by age and year from 1990 to 2017 as part of GBD 2017. We used a counterfactual approach that first estimated the LRTI incidence, hospitalisations, and mortality and then attributed a fraction of those outcomes to influenza. Findings Influenza LRTI was responsible for an estimated 145 000 (95% uncertainty interval [UI] 99 000–200 000) deaths among all ages in 2017. The influenza LRTI mortality rate was highest among adults older than 70 years (16·4 deaths per 100 000 [95% UI 11·6–21·9]), and the highest rate among all ages was in eastern Europe (5·2 per 100 000 population [95% UI 3·5–7·2]). We estimated that influenza LRTIs accounted for 9 459000 (95% UI 3 709000–22 935000) hospitalisations due to LRTIs and 81 536 000 hospital days (24 330 000–259851 000). We estimated that 11·5% (95% UI 10·0–12·9) of LRTI episodes were attributable to influenza, corresponding to 54481 000 (38465000–73864000) episodes and 8172000 severe episodes (5 000 000–13 296000). Interpretation This comprehensive assessment of the burden of influenza LRTIs shows the substantial annual effect of influenza on global health. Although preparedness planning will be important for potential pandemics, health loss due to seasonal influenza LRTIs should not be overlooked, and vaccine use should be considered. Efforts to improve influenza prevention measures are needed
    corecore